SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 10-Q



              [X] QUARTERLY REPORT UNDER SECTION 13 or 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                For the quarterly period ended September 30, 2004
                           Commission File No. 2-70197

                              OCEAN BIO-CHEM, INC.
--------------------------------------------------------------------------------
             (Exact name of Registrant as specified in its charter)


               Florida                                        59-1564329
--------------------------------------------          --------------------------
(State or other jurisdiction of                          (I.R.S. Employer
incorporation or organization)                          Identification No.)


Registrant's telephone number, including area code - (954) 587-6280

     Indicate  by check mark  whether the  Registrant  (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
Registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.

            YES   X                              NO
                ------                               -------

     Indicate by check mark whether the Registrant is an  Accelerated  Filer (as
defined in Rule 12b-2 of the Exchange Act)

            YES                                  NO     X
                ------                               -------


     Indicate the number of shares  outstanding of each of the Issuer's  classes
of common stock, as of the latest practicable date.

            $.01 Par Value Common Stock 10,000,000 shares authorized;
             5,417,813 issued and outstanding at September 30, 2004



<PAGE>



                         OCEAN BIO-CHEM AND SUBSIDIARIES

                                      INDEX


Description                                                             Page
                                                                        ----
Part I:

 Item 1. -  Financial Statements:

     Consolidated balance sheets as of September 30, 2004
       and December 31, 2003                                              3

     Consolidated statements of operations for the three and
       nine months ended September 30, 2004 and 2003                      4

     Consolidated statements of changes in shareholders'
       equity for the nine months ended September 30, 2004
       and 2003                                                           5

     Consolidated statements of cash flows for the nine months
       ended September 30, 2004 and 2003                                  6

 Item 2. -  Management's Discussion and Analysis of Financial
            Condition and Results of Operations                          7-8

Item 3. -  Quantitative and Qualitative Disclosures about Market Risk     9

Item 4. -  Controls and Procedures                                        9

Part II:

 Item 1. - Legal Proceedings                                             10
 Item 2. - Changes in Securities                                         10
 Item 3. - Defaults upon Senior Securities                               10
 Item 4. - Submission of Matters to Vote by Security Holders             10
 Item 5. - Other Matters                                                 10
 Item 6. - Exhibits and Reports on Form 8-K                              10

Signatures                                                               10

Exhibits













                                        2


<PAGE>
                         Part I - Financial Information

Item I. Financial Statements

                              OCEAN BIO-CHEM, INC.
                                AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS

                                     ASSETS
<TABLE>
<CAPTION>
                                                                    SEPTEMBER 30,       DECEMBER 31,
                                                                        2004               2003
                                                                    -------------       ------------
                                                                     (Unaudited)
<S>                                                                 <C>                 <C>
Current assets:
   Cash                                                             $     53,547        $     42,923
   Trade accounts receivable net of allowances for doubtful
     accounts of approximately $133,200 and $ 206,000 at
      September 30, 2004 and December 31, 2003, respectively           4,876,274           4,333,023
   Inventories
                                                                       6,484,544           5,315,741
   Prepaid expenses and other current assets                             161,950             193,372
                                                                    ------------        ------------
     Total current assets                                             11,576,315           9,885,059
                                                                    ------------        ------------

Property, plant and equipment, net                                     7,361,793           7,506,586
                                                                    ------------        ------------

Other assets:
   Funds held in escrow for equipment                                      1,901             126,295
   Trademarks, trade names and patents, net
     of accumulated amortization                                         330,439             330,439
   Due from affiliated companies, net                                    381,002             172,925
   Deposits and other assets                                             273,437             281,880
                                                                    ------------        ------------
       Total other assets                                                986,779             911,539
                                                                    ------------        ------------

      Total assets                                                  $ 19,924,887        $ 18,303,184
                                                                    ============        ============

                      LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:
   Accounts payable - trade                                         $  2,954,277        $  1,305,484
   Note payable - bank                                                 4,975,000           4,550,000
   Current portion of long-term debt                                     485,805             898,964
   Income taxes and accrued expenses payable                              61,522             261,439
                                                                    ------------        ------------

       Total current liabilities                                       8,476,604           7,015,887
                                                                    ------------        ------------

Deferred income taxes payable                                            241,610             205,610
                                                                    ------------        ------------

Long term debt, less current portion                                   5,699,925           5,677,692
                                                                    ------------        ------------

Shareholders' equity:
   Common stock - $.01 par value 10,000,000 shares authorized,
     5,417,813 and 4,960,843 issued and outstanding at
     September 30, 2004 and December 31, 2003, respectively               54,178              49,608
   Additional paid-in capital                                          4,722,746           4,409,829
   Foreign currency translation adjustment                          (    224,633)       (    237,323)
   Retained earnings                                                     962,652           1,190,076
                                                                    ------------        -------------
                                                                       5,514,943           5,412,190
   Less cost of common stock in treasury, 7,519 shares
     at September 30, 2004 and December 31, 2003, respectively      (      8,195)       (      8,195)
                                                                    -------------       -------------
                                                                       5,506,748           5,403,995
                                                                    -------------       -------------

Total liabilities and shareholders' equity                          $ 19,924,887        $ 18,303,184
                                                                    =============       =============
</TABLE>


                                        3
<PAGE>


                      OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (Unaudited)
<TABLE>
<CAPTION>


                                                  For the three months                     For the nine months
                                                   ended September 30,                       ended September 30,
                                                2004              2003                  2004              2003
                                                ----              ----                  ----              ----
<S>                                           <C>               <C>                  <C>                <C>
Gross sales                                   $6,513,764        $7,147,944           $16,713,144        $15,835,996

Allowances                                       626,276           715,394             1,942,509          1,421,928
                                              ----------        ----------           -----------        -----------

Net sales                                      5,887,488         6,432,550            14,770,635         14,414,068
Cost of goods sold                             4,671,283         4,675,359            11,414,361         10,851,142
                                              ----------        ----------           -----------        -----------

Gross profit                                   1,216,205         1,757,191             3,356,274          3,562,926
                                              ----------        ----------           -----------        -----------

Cost and expenses:
   Advertising and promotion                     370,879           313,256               838,309           640,580
   Selling and administrative                    864,241           754,069             2,586,392         2,361,976
   Interest expense                               81,285            70,642               222,227           218,333
                                              ----------        ----------           -----------        -----------
     Total costs and expenses                  1,316,405         1,137,967             3,646,928          3,220,889
                                              ----------        ----------           -----------        -----------

Income (loss) from operations                 (  100,200)          619,224           (   290,654)           342,037
Interest income                                      151             7,544                   730             10,778
                                              -----------       ----------           ------------       -----------

Income (loss) before income taxes             (  100,049)          626,768           (   289,924)           352,815

Provision (benefit) for income taxes          (   16,000)          120,000           (    62,500)           120,000
                                              -----------       ----------           ------------       -----------

Net income (loss)                             (   84,049)          506,768           (   227,424)           232,815

Other comprehensive income, net of
   income taxes:

 Foreign currency translation
   adjustment                                     24,711        (      708)               12,690             49,004
                                              -----------       -----------          ------------       ------------

Comprehensive income                          ($  59,338)       $  506,060           ($  214,734)       $   281,819
                                              ===========       ===========          ============       ===========

Earnings(loss) per common share               ($     .02)       $      .10           ($      .04)       $       .05
                                              ===========       ===========          ============       ===========

</TABLE>



     Earnings per share were  calculated on the basis of 5,335,816 and 4,866,605
weighted  average  shares of common  stock  outstanding  for the nine months and
three months ended September 30, 2004 and 2003, respectively.

     The Company has adopted  Statement of Financial  Accounting  Standards  No.
130, which requires  items of  comprehensive  income to be stated as part of the
basic  financial  statements.  The only  items of  comprehensive  income  of the
Registrant  which are reflected in the  accompanying  financial  statements  are
foreign currency translation adjustments.





                                        4


<PAGE>


                      OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
                        CONSOLIDATED STATEMENT OF CHANGES
                             IN SHAREHOLDERS' EQUITY
                            FOR THE NINE MONTHS ENDED
                           SEPTEMBER 30, 2004 AND 2003
                                   (UNAUDITED)

<TABLE>
<CAPTION>

                                                                             Foreign
                               Common stock               Additional         currency       Retained       Treasury
                            Shares         Amount      paid-in capital      adjustment      earnings         stock          Total
                            ------         ------      ---------------      ----------     ----------     -----------     ----------

<S>                         <C>            <C>            <C>               <C>            <C>            <C>             <C>
January 1,
   2004                     4,960,843        $49,608      $4,409,829        ($237,323)     $1,190,076     ($  8,195)    $5,403,995


Net loss                                                                                   (  227,424)                  (  227,424)

Common stock
   issuances                  456,970          4,570         312,917                                                       317,487

Foreign currency
   translation
   adjustment                                                                  12,690                                       12,690
                            ---------      ---------      ----------        ---------      -----------    ----------    ----------


September 30,
   2004                     5,417,813      $  54,178      $4,722,746        ($224,633)     $  962,652     ($  8,195)    $5,506,748
                            =========      =========      ==========        ==========     ==========     ==========    ==========
$5,506,748
==========


January 1,
   2003                     4,805,843        $48,058      $4,341,629        ($303,575)     $  845,005     ($  8,195)    $4,922,922


Net income                                                                                    232,815                      232,815

Common stock
   issuances                  155,000          1,550          68,200                                                        69,750

Foreign currency
   translation
   adjustment                                                                                  49,004                       49,004
                            ---------      ---------      ----------        ---------      -----------    ----------    -----------


September 30,
   2003                     4,960,843        $49,608      $4,409,829        ($254,571)     $1,077,820     ($  8,195)    $5,176,483
                            =========      =========      ==========        ==========     ==========     ==========    ===========




</TABLE>









                                        5


<PAGE>


                      OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                     FOR THE NINE MONTHS ENDED SEPTEMBER 30,
                                   (UNAUDITED)
<TABLE>
<CAPTION>

                                                                        2004                2003
                                                                        ----                ----

<S>                                                                 <C>                 <C>
Cash flows provided by operating activities:
      Net income (loss)                                             ($   227,424)       $    232,815
Adjustments to reconcile net income
   to net cash provided by operations:
         Depreciation and amortization                                   545,422             495,420
         Changes in assets and liabilities:
            (Increase) in accounts receivable                       (    543,251)       (  1,183,919)
            (Increase)  in inventory                                (  1,168,803)       (  1,609,951)
            (Increase) decrease in prepaid expenses
             and other current assets                                     31,422        (     87,335)
            Increase in accounts payable,
              accrued expenses, and other                              1,493,319             954,876
                                                                    -------------       -------------

         Net cash provided (used) by operating activities                130,685        (  1,198,094)
                                                                    -------------       -------------

Cash flows from financing activities:
      Net increases under line of credit                                 425,000             500,000
      Reduction (increases) in due from affiliates                  (    208,077)            298,041
      Payments on debts, net                                        (    390,926)       (    433,907)
      Common stock transactions                                          317,487              69,750
                                                                    -------------       -------------

         Net cash provided by operating activities                       143,484             433,884
                                                                    -------------       -------------

Cash flows from investing activities:
   Purchases of property, plant and equipment, net
      of funds held in escrow                                       (    276,235)       (    138,595)
                                                                    -------------       -------------

   Net cash used by investing activities                            (    276,235)       (    138,595)
                                                                    -------------       -------------

   (Decrease) in cash prior to effect of
      foreign currency translation adjustments                      (      2,066)       (    902,805)

   Effect of foreign currency translation on cash                         12,690              49,004
                                                                    -------------       -------------

   Net increase (decrease) in cash                                        10,624        (    853,801)

   Cash at beginning of period                                            42,923           1,093,826
                                                                    -------------       -------------

   Cash at end of period                                            $     53,547        $    240,025
                                                                    =============       =============

   Supplemental information:

   Cash used for payment of interest during period                  $    222,227        $    218,333
                                                                    =============       =============

   Cash used for payment of income taxes during period              $     48,000        $        -
                                                                    =============       =============

   The Company had no cash equivalents at September 30, 2004 or 2003.

</TABLE>



                                        6


<PAGE>


                      OCEAN BIO-CHEM, INC. AND SUBSIDIARIES
            NOTES TO THE CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

     The  information  contained in this Report is  unaudited,  but reflects all
adjustments  which are,  in the  opinion  of  management,  necessary  for a fair
statement of results of the interim periods, consisting only of normal recurring
accruals. The results for such interim periods are not necessarily indicative of
results to be expected for the full year.

     Certain  financial  statement  items for the three  and nine  months  ended
September  30,  2003 have been  reclassified  in order to conform  with the 2004
presentation.

Forward-looking Statements:

     Certain   statements   contained  herein,   including  without   limitation
expectations   as  to   future   sales   and   operating   results,   constitute
forward-looking statements pursuant to the safe harbor provisions of the Private
Securities  Litigations  Reform Act of 1995.  For this purpose,  any  statements
contained  in this  report that are not  statements  of  historical  fact may be
deemed  forward-looking  statements.  Without  limiting  the  generality  of the
foregoing,  words  such as  "may",  "will",  "expect",  "anticipate",  "intend",
"could" or the negative other variations  thereof or comparable  terminology are
intended to identify forward-looking statements.  These statements involve known
and  unknown  risks,  uncertainties  and other  factors  which may cause  actual
results,  performance or achievements of the Company to be materially  different
from any future  results,  performance or  achievements  expressed or implied by
such forward-looking statements.  Factors which may affect the Company's results
include,  but are not limited to, the highly competitive nature of the Company's
industry;  reliance  on  certain  key  customers;  consumer  demand  for  marine
recreational  vehicle  and  automotive  products;  advertising  and  promotional
efforts,  and other  factors.  The Company will not undertake  and  specifically
declines any obligation to update or correct any  forward-looking  statements to
reflect events or circumstances  after the date of such statements or to reflect
the occurrence of anticipated or unanticipated events.

     ITEM 2  MANAGEMENT'S  DISCUSSION  AND ANALYSIS OF FINANCIAL  CONDITION  AND
RESULTS OF OPERATIONS

Liquidity and Capital Resources

     The primary sources of our liquidity are cash from  operations,  short-term
borrowings  under our  revolving  line of credit with Regions Bank, a commercial
bank, and other borrowings.

     We renewed our line of credit with Regions Bank in July 2004, at which time
we increased our credit line from $5 million to $6 million.  This line of credit
is  collateralized  by a  security  interest  in  our  accounts  receivable  and
inventory.  The line of credit bears  interest at the  lender's  prime rate plus
..25% and  matures on May 31,  2005.  The  maximum  amount of credit  that can be
extended  under the agreement is $6 million.  Under this line of credit,  we are
required to maintain certain  financial ratios as of each fiscal year end. As of
September 30, 2004, the amount outstanding  pursuant to the working capital line
of credit was $ 4,975,000.

     We have obtained financing under industrial  development revenue bonds from
the city of  Montgomery,  AL during 1997 and 2002. As of September 30, 2004, the
amount  outstanding under our industrial  development  bonds is $5,780,000.  The
bonds  carry a  floating  interest  rate,  which as of  September  30,  2004 was
approximately 2%.

     Result of Operations for the Three Months Ended September 30, 2004 compared
to the Three Months Ended September 30, 2003:

     Gross sales  decreased  9% or  approximately  $634,200 for the three months
ended  September 30, 2004 compared to the three months ended September 30, 2003.
Management  attributes this decrease  primarily to the timing of incoming orders
resulting from the hurricanes that plagued the southeastern United States during
the current quarter.  Customer orders anticipated during the current period have
been received  during the fourth  quarter and it is expected that this shortfall
will be made up before year-end.





                                        7


<PAGE>



     Cost of goods sold  increased to 79.3% of net sales during the three months
ended  September  30, 2004  compared  to 72.7% of net sales in the three  months
ended  September  30, 2003.  The increase in the cost of goods is  attributed to
increasing  oil and other raw material costs  announced by suppliers  during the
current  quarter.  Our 2004 third  quarter sales  heavily  included  anti-freeze
products  which have margins that are highly  dependent on petroleum  costs.  In
addition,  the sales  that  otherwise  would  have been  reflected  in the third
quarter,  but for  the  impact  of  hurricanes  as  noted  above,  substantially
represent core marine  products  which yield higher margins and otherwise  would
have impacted the current quarter's revenue mix and, accordingly, gross margins.

     Selling and administrative  expenses increased approximately $110,200 or 15
% in the three months ended  September  30, 2004  compared to the same period of
the prior year.  Such change was primarily due to increased  personnel costs and
other normal recurring increases in operating expenses.

     Advertising  and promotion  increased  approximately $ 57,600 or 18% in the
three months ended  September  30, 2004 compared to the same period in the prior
year.  This resulted  primarily  from planned  increases in primarily  co-op and
print media advertising programs.

     Interest  expense for the three months ended September 30, 2004 amounted to
approximately  $81,300 which represents an approximate $10,000 increase compared
to the comparable  period in 2003.  This resulted from slightly  higher interest
rates and increased borrowings.

     Our loss from operations was approximately  ($100,000) for the three months
ended September 30, 2004 compared to income of approximately $626,800 during the
three months ended September 30, 2003.

     Our  net  loss  was  approximately  ($84,000)  in the  three  months  ended
September 30, 2004 compared to net income of approximately $506,800 in the three
months ended September 30, 2003.

     Result of Operations for the Nine Months Ended  September 30, 2004 compared
to the Nine Months Ended September 30, 2003:

     Gross sales  increased 6% to  approximately  $16,713,100 in the nine months
ended  September  30, 2004  compared to  $15,836,000  for the nine months  ended
September  30, 2003.  Management  attributes  this to sales  increases  realized
during  earlier  quarters of 2004 based on an early start to the marine  boating
season this year.

     Cost of goods  sold  increased  to 77.3% of net sales  for the nine  months
ended September 30, 2004 compared to 75.3% of net sales in the nine months ended
September 30, 2003.  This change  resulted from various  factors,  some of which
negatively   impacted   margins  and  others  which   mitigated  these  factors.
Specifically, petroleum product costs are higher than those experienced in prior
periods and currently represent a higher portion of manufacturing  expenses.  In
addition, a price increase was passed along on certain products during the first
quarter of 2004, and margins are favorably  impacted by spreading fixed elements
of  overhead  over  increased  revenues.  Please  read  management's  discussion
relating to the three months ended September 30, 2004, above.

     Advertising and promotion expenses increased approximately $197,700 for the
2004  period when  compared to expenses in the same time period in the  previous
year.  This  increase  resulted   primarily  from  increased  co-op  advertising
associated with increased  sales to certain  customers and the timing of various
advertising programs in 2004.

     Selling and administrative  expenses increased by approximately $224,400 or
10% in the nine months  ended  September  30,  2004  compared to the nine months
ended September 30, 2003.  Such change was primarily due to increased  personnel
costs and other normal recurring increases in operating expenses.

     Interest  expense for the 2004 period increased  approximately  $3,900 when
compared to the same nine month period of 2003. This change was primarily due to
the impact of higher interest rates and increased borrowings.






                                        8

<PAGE>

ITEM 3      QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

     Market  risk  represents  the risk of loss that may  impact  our  financial
position,  results  of  operations  or cash  flows  due to  adverse  changes  in
financial and  commodity  market  prices and interest  rates.  We are exposed to
market risk in the areas of changes in borrowing  rates in the United States and
changes in foreign currency  exchange rates.  Historically,  and as of September
30,  2004,  we have  not used  derivative  instruments  or  engaged  in  hedging
activities to minimize market risk.

INTEREST RATE RISK

     As or September 30, 2004, we had floating  interest rates on our industrial
development revenue bonds and our working capital line of credit facility. As of
September 30, 2004, the interest rate on our $5,780,000  outstanding  balance of
industrial revenue bonds was approximately 2% per annum and the interest rate on
our line of credit facility  approximated 5% which is prime plus .25%. We do not
expect any  changes in the  interest  rate to have a  significant  impact on our
operations during fiscal 2004.

FOREIGN CURRENCY RISK

     We sell products in Canada, based on the Canadian dollar.  Thereby, we have
exposure  to changes in  exchange  rates.  Changes in the  Canadian  dollar/U.S.
dollar  exchange  rates may  positively or negatively  affect our gross margins,
operating income and retained earnings. We do not believe that near-term changes
in the exchange  rates,  if any, will result in a material  effect on our future
earnings,  fair values or cash flows, and therefore, we have chosen not to enter
into  foreign  currency  hedging  transactions.  We cannot  assure you that this
approach will be successful, especially in the event of a significant and sudden
change in the value of the Canadian dollar.

CONCENTRATION AND CREDIT RISK

     We maintain  cash  balances  at several  financial  institutions  which are
insured by the Federal Deposit Insurance  Corporation up to $100,000.  At times,
the cash balances may exceed federally  insured limits.  We have not experienced
any losses in such accounts and we believe the risk related to these deposits is
minimal.


ITEM 4.  CONTROLS AND PROCEDURES

     Within 90 days prior to the date of this Quarterly  Report on Form 10-Q, we
carried out an evaluation,  under the supervision and with the  participation of
our  principal  executive  officer  and  principal  financial  officer,  of  the
effectiveness  of the  design  and  operation  of our  disclosure  controls  and
procedures.  Based on this  evaluation,  our  principal  executive  officer  and
principal   financial  officer  concluded  that  our  disclosure   controls  and
procedures  are  effective  in  timely  alerting  them to  material  information
required to be included in our periodic SEC reports. It should be noted that the
design of any system of controls is based in part upon certain assumptions about
the likelihood of future  events,  and there can be no assurance that any design
will  succeed  in  achieving  its  stated  goals  under  all  potential   future
conditions,  regardless  of how remote.  In  addition,  we reviewed our internal
controls, and there have been no significant changes in our internal controls or
in other factors that could  significantly  affect those controls  subsequent to
the date of their last evaluation.














                                        9

<PAGE>


                           PART II - OTHER INFORMATION

Item 1 - Legal Proceedings:  See our Form 10-K for the year ended
                               December 31, 2003.

Item 2 - Changes in Securities:  Not applicable

Item 3 - Defaults Upon Senior Securities:  Not applicable

Item 4 - Submission of Matters to Vote of Security Holders:  Not applicable

Item 5 - Other Matters:  Not applicable

Item 6 - Exhibits and Reports on Form 8-K:

(A)      Exhibits:  Not applicable

(B) Reports on Form 8-K:

     On October  26,  2004,  we filed a Form 8-K  disclosing  that,  pursuant to
NASDAQ rules covering  controlled  corporations (those with a shareholder owning
more than 50% of a company's common stock), we do not have either an independent
compensation committee or nominating committee.


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant has duly caused this report to be signed on behalf by the Undersigned
there unto duly authorized.

   OCEAN BIO-CHEM, INC.

Date:          November 12, 2004             /s/        Peter G. Dornau
     -----------------------------           -----------------------------------
                                             Peter G. Dornau
                                             Chairman of the Board of Directors
                                             and Chief Executive Officer


                                             /s/        Edward Anchel
                                             -----------------------------------
                                             Edward Anchel
                                             Chief Financial Officer



















                                       10


<PAGE>


                                                                      Exhibit 31
                                  CERTIFICATION


I, Peter G. Dornau certify that:

     1. I have reviewed this  quarterly  report on Form 10-Q of Ocean  Bio-Chem,
Inc. as of and for the periods ended September 30, 2004;

     2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not misleading with respect to the periods covered by this report;

     3. Based on my knowledge,  the financial  statements,  and other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the Registrant as
of, and for, the periods presented in this report;

     4. The  Registrant's  other  certifying  officer and I are  responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a - 15(e) and 15d - 15(e)) for the Registrant and have:

     a)  Designed  such  disclosure  controls  and  procedures,  or caused  such
disclosure  controls and  procedures to be designed  under our  supervision,  to
ensure that  material  information  relating to the  Registrant,  including  its
consolidated subsidiaries,  is made known to us by others within those entities,
particularly during the period in which this quarterly report is being prepared;

     b) Evaluated the effectiveness of the Registrant's  disclosure controls and
procedures and presented in this report our conclusions  about the effectiveness
of the disclosure  controls and procedures , as of the end of the period covered
by this report based on such evaluation; and

     c) Disclosed in this report any change in the Registrant's internal control
over  financial  reporting  that occurred  during the  Registrant's  most recent
fiscal  quarter  that  has  materially  affected,  or is  reasonably  likely  to
materially affect, the Registrant's  internal control over financial  reporting;
and

     5. The registrant's other certifying officer and I have disclosed, based on
our most recent evaluation of internal control over financial reporting,  to the
Registrant's auditors and the audit committee of Registrant's board of directors
(or persons performing the equivalent function):

     a) All significant  deficiencies  and material  weaknesses in the design or
operation of internal  control over  financial  reporting  which are  reasonably
likely  to  adversely  affect  the  Registrant's  ability  to  record,  process,
summarize and report financial information; and

     b) Any fraud,  whether or not material,  that involves  management or other
employees who have a significant role in the Registrant's  internal control over
financial reporting.

     OCEAN BIO-CHEM, INC.

     Date:    November 12, 2004              /s/ Peter G. Dornau
             -------------------             ----------------------
                                             Peter D. Dornau
                                             Chairman of the Board and
                                             Chief Executive Officer







<PAGE>

                                                                    Exhibit 31.1


                                  CERTIFICATION

I, Edward Anchel certify that:

     1. I have reviewed this  quarterly  report on Form 10-Q of Ocean  Bio-Chem,
Inc. as of and for the periods ended September 30, 2004;

     2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not misleading with respect to the periods covered by this report;

     3. Based on my knowledge,  the financial  statements,  and other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the Registrant as
of, and for, the periods presented in this report;

     4. The  Registrant's  other  certifying  officer and I are  responsible for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a - 15(e) and 15d - 15(e)) for the Registrant and have:

     a)  Designed  such  disclosure  controls  and  procedures,  or caused  such
disclosure  controls and  procedures to be designed  under our  supervision,  to
ensure that  material  information  relating to the  Registrant,  including  its
consolidated subsidiaries,  is made known to us by others within those entities,
particularly during the period in which this quarterly report is being prepared;

     b) Evaluated the effectiveness of the Registrant's  disclosure controls and
procedures and presented in this report our conclusions  about the effectiveness
of the disclosure  controls and procedures , as of the end of the period covered
by this report based on such evaluation; and

     c) Disclosed in this report any change in the Registrant's internal control
over  financial  reporting  that occurred  during the  Registrant's  most recent
fiscal  quarter  that  has  materially  affected,  or is  reasonably  likely  to
materially affect, the Registrant's  internal control over financial  reporting;
and

     5. The registrant's other certifying officer and I have disclosed, based on
our most recent evaluation of internal control over financial reporting,  to the
Registrant's auditors and the audit committee of Registrant's board of directors
(or persons performing the equivalent function):

     a) All significant  deficiencies  and material  weaknesses in the design or
operation of internal  control over  financial  reporting  which are  reasonably
likely  to  adversely  affect  the  Registrant's  ability  to  record,  process,
summarize and report financial information; and

     b) Any fraud,  whether or not material,  that involves  management or other
employees who have a significant role in the Registrant's  internal control over
financial reporting.


   OCEAN BIO-CHEM, INC.

   Date:    November 12, 2004                /s/ Edward Anchel
                                             ------------------------
                                             Edward Anchel
                                             Chief Financial Officer


<PAGE>



                                                                      Exhibit 32



                                  CERTIFICATION

     Pursuant  to  18U.S.C.Section  1350,  the  undersigned  officers  of  Ocean
Bio-Chem,  Inc. (the  "Company"),  hereby  certify that the Company's  Quarterly
Report on Form 10-Q for the quarter  ended  September  30,  2004 (the  "Report")
fully complies with the  requirements  of Section 13(a) or 15(d), as applicable,
of the Securities Exchange Act of 1934 and that the information contained in the
Report fairly presents,  in all material respects,  the financial  condition and
results of operation of the Company.

   Dated:  November 12, 2004

                                             /s/ Peter Dornau
                                             ------------------------
                                             Peter G. Dornau
                                             Chairman  of the  Board
                                             of Directors and
                                             Chief Executive Officer




                                             /s/ Edward Anchel
                                             ------------------------
                                             Edward Anchel
                                             Chief Financial Officer